The global search and commercialization of alternatives and substitutes for ozone-depleting substances - 22/11/18
pages | 15 |
Iconographies | 1 |
Vidéos | 0 |
Autres | 0 |
Abstract |
The Montreal Protocol has halted 99% of global production of chemical substances that deplete stratospheric ozone, which protects life on earth from the harmful effects of ultraviolet (UVB) radiation. UVB causes skin cancer and cataracts, suppresses the human immune system, destroys plastics, and damages agricultural crops and natural ecosystems. Because ozone-depleting substances (ODSs) are powerful greenhouse gases, the Montreal Protocol also protects climate. From the authors’ perspectives in multiple roles as environmental entrepreneurs, practitioners, and authorities, this paper explains how individuals, companies, and military organizations researched, developed, commercialized and implemented alternatives to ODSs that are also safer for climate. With the benefit of hindsight, the authors reflect on what was neglected or done badly under the Montreal Protocol and present lessons learned on how Montreal Protocol institutions can be renewed and revitalized to phase down hydrofluorocarbons (HFCs).
Le texte complet de cet article est disponible en PDF.Keywords : Montreal Protocol, Stratospheric ozone, Climate: Kigali amendment
Plan
☆ | The findings of this paper were presented at the Symposium for the 30th Anniversary of the Montreal Protocol, Foundation Del Duca, Paris, on 18 and 19 September 2017. The authors are grateful for the scholarship of Nathan Borgford-Parnell, Dr. Penelope Canan, K. Madhava Sarma, Kristen Taddonio, and Durwood Zaelke, who inspired and informed this paper. Much of the scientific history presented in this paper is elaborated in Andersen et al., 2014 . Please refer to the PowerPoint slides for sectoral elaboration. [LINK to Paris PowerPoint: Velders_30MP_Symposium_Paris_Sept2017.pdf]. |
Vol 350 - N° 7
P. 410-424 - novembre 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?